These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24690253)

  • 21. Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.
    Niermeyer M; Gaudet C; Malloy P; Piryatinsky I; Salloway S; Klinge P; Lee A
    J Int Neuropsychol Soc; 2020 Oct; 26(9):883-893. PubMed ID: 32430087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
    Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
    Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
    J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
    Miyajima M; Nakajima M; Ogino I; Miyata H; Motoi Y; Arai H
    Eur J Neurol; 2013 Feb; 20(2):236-42. PubMed ID: 22672777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.
    Thavarajasingam SG; El-Khatib M; Vemulapalli KV; Iradukunda HAS; Laleye J; Russo S; Eichhorn C; Eide PK
    Acta Neurochir (Wien); 2022 Jul; 164(7):1719-1746. PubMed ID: 35230552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.
    Lukkarinen H; Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Hiltunen M; Rauramaa T; Nägga K; Leinonen V; Tullberg M
    Fluids Barriers CNS; 2022 Feb; 19(1):11. PubMed ID: 35123528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
    Braun M; Bjurnemark C; Seo W; Freyhult E; Nyholm D; Niemelä V; Blennow K; Zetterberg H; Fällmar D; Kultima K; Virhammar J
    Fluids Barriers CNS; 2022 Feb; 19(1):15. PubMed ID: 35164790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
    Jang H; Park SB; Kim Y; Kim KW; Lee JI; Kim ST; Lee KH; Kang ES; Choe YS; Seo SW; Kim HJ; Kim YJ; Yoon CW; Na DL
    J Neurol; 2018 Jan; 265(1):63-73. PubMed ID: 29128930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus.
    Weiner S; Junkkari A; Sauer M; Luikku A; Rauramaa T; Kokkola T; Herukka SK; Blennow K; Zetterberg H; Leinonen V; Gobom J
    Fluids Barriers CNS; 2023 Jun; 20(1):40. PubMed ID: 37277809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal pentraxin 2 correlates with neurodegeneration but not cognition in idiopathic normal pressure hydrocephalus (iNPH).
    Patel M; Zhang Y; Xiao MF; Worley P; Moghekar A
    Neurol Neurochir Pol; 2024; 58(1):47-53. PubMed ID: 38393959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Vanninen A; Lukkarinen H; Kokkola T; Koivisto AM; Kokki M; Musialowicz T; Hiltunen M; Zetterberg H; Leinonen V; Herukka SK; Rauramaa T
    J Alzheimers Dis; 2023; 94(2):727-736. PubMed ID: 37334597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.
    Hiraldo-González L; Trillo-Contreras JL; García-Miranda P; Pineda-Sánchez R; Ramírez-Lorca R; Rodrigo-Herrero S; Blanco MO; Oliver M; Bernal M; Franco-Macías E; Villadiego J; Echevarría M
    PLoS One; 2021; 16(10):e0258165. PubMed ID: 34597351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain tissue Aβ42 levels are linked to shunt response in idiopathic normal pressure hydrocephalus.
    Abu Hamdeh S; Virhammar J; Sehlin D; Alafuzoff I; Cesarini KG; Marklund N
    J Neurosurg; 2019 Jan; 130(1):121-129. PubMed ID: 29350601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.
    Santangelo R; Cecchetti G; Bernasconi MP; Cardamone R; Barbieri A; Pinto P; Passerini G; Scomazzoni F; Comi G; Magnani G
    J Alzheimers Dis; 2017; 60(1):183-200. PubMed ID: 28826180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
    Herukka SK; Rummukainen J; Ihalainen J; von Und Zu Fraunberg M; Koivisto AM; Nerg O; Puli LK; Seppälä TT; Zetterberg H; Pyykkö OT; Helisalmi S; Tanila H; Alafuzoff I; Hiltunen M; Rinne J; Soininen H; Jääskeläinen JE; Leinonen V
    J Alzheimers Dis; 2015; 46(1):261-9. PubMed ID: 25720406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Kawamura K; Kamohara C; Fusegi K; Harada Y; Hara T; Sugano H; Tange Y; Karagiozov K; Kasuga K; Ikeuchi T; Tokuda T; Arai H
    J Alzheimers Dis; 2018; 66(1):319-331. PubMed ID: 30248058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade.
    Moriya M; Miyajima M; Nakajima M; Ogino I; Arai H
    PLoS One; 2015; 10(3):e0119973. PubMed ID: 25821958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Kawamura K; Miyajima M; Nakajima M; Kanai M; Motoi Y; Nojiri S; Akiba C; Ogino I; Xu H; Kamohara C; Yamada S; Karagiozov K; Ikeuchi T; Kondo A; Arai H
    J Alzheimers Dis; 2021; 83(1):179-190. PubMed ID: 34275898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus.
    Kamohara C; Nakajima M; Kawamura K; Akiba C; Ogino I; Xu H; Karagiozov K; Arai H; Miyajima M
    Acta Neurol Scand; 2020 Dec; 142(6):623-631. PubMed ID: 32619270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.